Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E FREI

Showing results (291-300 of 428) with videos related to

Pageof 43
Sort By:
International Journal of Cancer|June 19, 1991
Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivoJ Tanaka, B A Teicher, T S Herman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Combination of etanidazole with cyclophosphamide and platinum complexesB A Teicher, T S Herman, L Shulman, et al.
Cancer Research|September 1, 1979
A Phase 1 study of high doses of aminopterin with leucovorin rescue in patients with advanced metastatic tumorsL M Glode, S W Pitman, W D Ensminger, et al.
Neuroreport|February 23, 2000
Mood state and brain electric activity in ecstasy usersA Gamma, E Frei, D Lehmann, et al.
Development (Cambridge, England)|November 11, 1999
double-time is identical to discs overgrown, which is required for cell survival, proliferation and growth arrest in Drosophila imaginal discsO Zilian, E Frei, R Burke, et al.
Journal of Surgical Oncology|April 1, 1989
Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: long-term follow-up in 41 patientsA Skarin, M Jochelson, T Sheldon, et al.
Cancer Research|September 1, 1986
Alkylating agents: in vitro studies of cross-resistance patterns in human cell linesB A Teicher, C A Cucchi, J B Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1988
Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolismM L Sherman, D R Spriggs, K A Arthur, et al.
Cancer Treatment Reports|March 1, 1981
Phase I trial of combination therapy with PALA and 5-FUM W Meshad, T J Ervin, D Kufe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
High-dose ifosfamide with mesna uroprotection: a phase I studyA D Elias, J P Eder, T Shea, et al.
Pageof 43

Showing results (291-300 of 428) with videos related to

Sort By:
Pageof 43
International Journal of Cancer|June 19, 1991
Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivoJ Tanaka, B A Teicher, T S Herman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Combination of etanidazole with cyclophosphamide and platinum complexesB A Teicher, T S Herman, L Shulman, et al.
Cancer Research|September 1, 1979
A Phase 1 study of high doses of aminopterin with leucovorin rescue in patients with advanced metastatic tumorsL M Glode, S W Pitman, W D Ensminger, et al.
Neuroreport|February 23, 2000
Mood state and brain electric activity in ecstasy usersA Gamma, E Frei, D Lehmann, et al.
Development (Cambridge, England)|November 11, 1999
double-time is identical to discs overgrown, which is required for cell survival, proliferation and growth arrest in Drosophila imaginal discsO Zilian, E Frei, R Burke, et al.
Journal of Surgical Oncology|April 1, 1989
Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: long-term follow-up in 41 patientsA Skarin, M Jochelson, T Sheldon, et al.
Cancer Research|September 1, 1986
Alkylating agents: in vitro studies of cross-resistance patterns in human cell linesB A Teicher, C A Cucchi, J B Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1988
Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolismM L Sherman, D R Spriggs, K A Arthur, et al.
Cancer Treatment Reports|March 1, 1981
Phase I trial of combination therapy with PALA and 5-FUM W Meshad, T J Ervin, D Kufe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
High-dose ifosfamide with mesna uroprotection: a phase I studyA D Elias, J P Eder, T Shea, et al.
Pageof 43